Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery

ClinicalTrials.gov ID: NCT02793492

Public ClinicalTrials.gov record NCT02793492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.

Study identification

NCT ID
NCT02793492
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Terumo Medical Corporation
Industry
Enrollment
75 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2022 (Actual)
Primary completion
Feb 24, 2025 (Actual)
Completion
Jul 1, 2026 (Actual)
Last update posted
Jul 23, 2026

2022 – 2026

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
ClinRe Inc. Advanced Heart and Vein Center Thornton Colorado 80023 —
University of Florida Health Gainesville Florida 32610 —
First Coast Cardiovascular Institute Jacksonville Florida 32256 —
Cardiovascular Institute of the South Lafayette Louisiana 70506 —
Holy Name Medical Center Teaneck New Jersey 07666 —
Novant Health Matthews North Carolina 28105 —
The Christ Hospital Cincinnati Ohio 45219 —
Texas Tech University Health Sciences Center Lubbock Texas 79430 —
The Heart Hospital Baylor Plano Plano Texas 75093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02793492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02793492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →